Trial Information

Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

- It is important to understand that even if the participant consents to allow us to save
their leukemia cells, we cannot guarantee that they will be able to receive a vaccine.
First, we may not be able to make enough vaccine from the collected cells. Second,
they may not be able to participate in a vaccine study in the future for reasons
related to the status of your overall health. Third, an appropriate vaccine trial may
not be available in the future.

- In order to make the vaccine, leukemia cells will be collected by one or more of the
following methods: drawing blood during one of two visits to the clinic;
leukapheresis; bone marrow aspiration; or, surgery to remove a lymph node.

- The physician will discuss with the participant which approach is best in their case to
ensure the highest number of tumor cells collected.